Interestingly, we found a high frequency of CD44+/CD24− BCSCs in LIPH + TNBC tumours, where LIPH silencing decreased the ratio of CD44+/CD24− stem‐like cells in vitro and blocked their mammosphere‐forming ability. The gene discussed is LIPH; the disease is neoplasm.